cytarabine has been researched along with Red-Cell Aplasia, Pure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hale, G; Kussman, A; Oshrine, B; Petrovic, A; Shyr, D | 1 |
| Chalandon, Y; Helg, C; Stalder, M; Verholen, F | 1 |
| Cortes, J; Freireich, EJ; Gajewski, J; Giles, FJ; Kantarjian, HM; Koller, C; Kornblau, S; O'Brien, S; Rios, MB; Sacchi, S; Talpaz, M | 1 |
| Idel'son, LI; Kolesnikova, AS; Pivnik, AV | 1 |
| Abe, T; Aoki, Y; Hanada, T; Nagasawa, T; Nakazawa, M; Ninomiya, H; Shibuya, A | 1 |
1 trial(s) available for cytarabine and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Combined Modality Therapy; Cytarabine; Drug Administration Schedule; Female; Femur Head Necrosis; Humans; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytosis; Life Tables; Male; Middle Aged; Paranoid Disorders; Pilot Projects; Pseudotumor Cerebri; Pulmonary Edema; Red-Cell Aplasia, Pure; Remission Induction; Survival Analysis; Syncope; Treatment Outcome; Tretinoin | 1999 |
4 other study(ies) available for cytarabine and Red-Cell Aplasia, Pure
| Article | Year |
|---|---|
Allogeneic hematopoietic cell transplantation in chemotherapy-induced aplasia in children with high-risk acute myeloid leukemia or myelodysplasia.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prognosis; Red-Cell Aplasia, Pure; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2019 |
Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.
Topics: ABO Blood-Group System; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Group Incompatibility; Blood Transfusion; Combined Modality Therapy; Cytarabine; Drug Resistance; Erythropoietin; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Killer Cells, Natural; Leukemia, Myelomonocytic, Acute; Leukocyte Transfusion; Male; Middle Aged; Plasmapheresis; Red-Cell Aplasia, Pure; Remission Induction; Rituximab; Transplantation, Homologous | 2004 |
[The successful treatment of partial red-cell aplasia of the bone marrow with low doses of cytosar and chlorbutin].
Topics: Blood Transfusion; Chlorambucil; Combined Modality Therapy; Cytarabine; Drug Therapy, Combination; Erythrocyte Transfusion; Female; Humans; Middle Aged; Red-Cell Aplasia, Pure; Remission Induction | 1989 |
Immunological erythroblastopenia induced by HCO-60 as a solvent of enocitabine (BH-AC).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Castor Oil; Cytarabine; Erythroblasts; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Male; Red-Cell Aplasia, Pure; Solvents | 1987 |